Peking University First Hospital

This study tests whether adding darolutamide to standard hormone therapy after prostate removal can delay cancer return in high-risk patients. About 40 men will receive the combination for 2 years. The main goal is to see how many stay cancer-free based on PSA levels.

This study tests a treatment plan for a rare cancer of the kidney and ureter that avoids removing the whole kidney. Patients first have a less invasive surgery to remove the tumor, then receive targeted drugs and radiation. The goal is to see if this approach can prevent the canc…

This study tests whether a supplement called TUDCA, taken by breastfeeding mothers with a fatty liver condition (MASLD), can improve health outcomes for their babies. Researchers will enroll 80 mother-infant pairs identified as high-risk based on a breast milk test. The goal is t…

This trial tests if islet cells made from stem cells can safely help people with diabetes. About 30 adults who have had diabetes for over 5 years and use insulin will receive an infusion of these cells. The goal is to see if the cells can improve blood sugar control and reduce th…

This study is for people with a type of kidney/urinary tract cancer who have had surgery but are at high risk of the cancer coming back. It compares two different follow-up treatments to see which is better at keeping the cancer away. One treatment combines a targeted drug with r…

This study will follow 1,000 men with suspected prostate cancer to see if repeated MRI scans can help doctors decide when a biopsy is truly needed. By watching how suspicious spots on MRI change over time, the goal is to avoid unnecessary biopsies while still catching dangerous c…

This study will test a new type of PET/CT scan that uses a special tracer (68Ga-BCMA) to find active multiple myeloma lesions throughout the body. The goal is to see if this scan can accurately detect the disease compared to standard biopsy. About 300 people with suspected or kno…

This study looks at whether giving older adults (65-90) a combination of two medicines (dexmedetomidine and esketamine) along with a gentle brain stimulation technique (tDCS) during and after surgery can prevent long-term memory and thinking problems. The researchers will follow …

This study tests whether giving older adults (65-90 years) a combination of two medicines (dexmedetomidine and esketamine) along with a gentle brain stimulation technique (tDCS) before and after surgery can prevent confusion and memory problems. About 1,160 participants will be f…

This study tests whether a drug called esketamine can reduce confusion and memory problems in older adults after major non-cardiac surgery. Researchers will compare three different doses in 120 patients aged 65 to 90. The goal is to find the dose that best protects brain function…

This study tests whether giving a combination of two medicines (dexmedetomidine and esketamine) before and after spinal surgery can lower the chance of long-term pain. About 274 adults aged 40 to 79 having spine surgery will take part. The goal is to see if this drug combo works …

This study tests if the drug tamsulosin can prevent urination difficulties after a prostate biopsy in men. About 1,844 men will either take tamsulosin for 10 days around their biopsy or receive no preventive medication. The goal is to see if the drug reduces the risk of being una…

This study tests whether giving a combination of two drugs (dexmedetomidine and esketamine) during and after spinal surgery can lower the chance of moderate-to-severe pain in the first three days after the operation. About 274 adults aged 40 to 79 having spine surgery will take p…

This study looks at how different depths of anesthesia affect thinking and memory recovery in older adults (65+) after non-heart surgery. Researchers will use a fixed ratio of two common anesthetics to see if a specific depth reduces confusion or memory loss. 200 participants wil…

This study will follow about 2,500 adults with liver cirrhosis to learn why some develop a dangerous blood clot in the liver's main vein (portal vein thrombosis). Researchers will review past cases and track new patients for two years to build a prediction tool, measure how the c…

This study looks at 50 adults with AL amyloidosis who achieved complete remission after initial chemotherapy. Researchers want to see if finding small traces of the disease (called minimal residual disease) can help guide further treatment, like stem cell transplants, to improve …